A research team from the Department of Pharmacology and Pharmacy, LKS Faculty of Medicine of the University of Hong Kong ...

Patients with glucocorticoid-induced osteoporosis on romosozumab show greater gains in lumbar spine bone mineral density than those on denosumab and comparable gains with those on teriparatide.

Some people can take “drug holidays” for years, sometimes, to keep the bone from becoming “frozen” and brittle.

A common medicine used to treat weak bones may also help protect the brain, according to a new large study from researchers ...

A new paper published in Osteoporosis International describes the rigorous, user-centered development of "Build Better Bones, ...

Treatment with GLP-1 RAs for T2D and obesity is associated with increased risk for osteoporosis, gout, and osteomalacia ...

Osteoporosis is a common disorder in which bones lose density and become more fragile. Over time, that raises the risk of ...

GLP-1RAs are associated with greater annualized total hip bone loss in patients without diabetes, driven primarily by weight ...